Advanced search
Publication Cover
Journal of Inflammation Research Volume 15, 2022 - Issue
Submit an article Journal homepage
128
Views
1
CrossRef citations to date
0
Altmetric
CASE SERIES

Therapeutic Plasma Exchanges in Combination with High-Dose Steroid-Induced Immunosuppression as an Ultima Ratio Therapy in Severe Coronavirus Disease 2019 (COVID-19): A Case-Series Report

Agata Janikowska1 Department of Nephrology and Diabetology, Carl-Thiem Hospital, Cottbus, GermanyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-1877-742X
ORCID Icon,
Jens Soukup2 Clinic for Anesthesiology, Intensive Therapy and Palliative Medicine, Carl-Thiem Hospital, Cottbus, Germany
,
Rainer U Pliquett1 Department of Nephrology and Diabetology, Carl-Thiem Hospital, Cottbus, GermanyORCID Iconhttps://orcid.org/0000-0001-9684-0618
ORCID Icon &
Rabah Abdel-Rahim1 Department of Nephrology and Diabetology, Carl-Thiem Hospital, Cottbus, Germany
Pages 715-722 | Published online: 03 Feb 2022

References

  • Horby P, Lim WS, et al; RECOVERY Collaborative Group. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021;384(8):693–704. doi:10.1056/NEJMoa2021436
  • Hayıroğlu Mİ, Çınar T, Tekkeşin Aİ. Fibrinogen and D-dimer variances and anticoagulation recommendations in Covid-19: current literature review. Rev Assoc Med Bras. 2020;66(6):842–848. doi:10.1590/1806-9282.66.6.842
  • Westblade LF, Simon MS, Satlin MJ. Bacterial coinfections in coronavirus disease 2019. Trends Microbiol. 2021;29(10):930–941. doi:10.1016/j.tim.2021.03.018
  • Gürün Kaya A, Öz M, Erol S, Çiftçi F, Çiledağ A, Kaya A. High flow nasal cannula in COVID-19: a literature review. COVID-19ʹda yüksekakımlınazalkanüloksijenkullanımı: literatürtaraması. TuberkToraks. 2020;68(2):168–174. doi:10.5578/tt.69807
  • World Health Organization. Report of the WHO-China joint mission on Coronavirus Disease 2019 (COVID-19) 16–24 February 2020 [Internet]. Geneva: World Health Organization; 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf. Accessed January 26, 2022.
  • Truong AD, Auld SC, Barker NA, et al. Therapeutic plasma exchange for COVID-19-associated hyperviscosity. Transfusion. 2021;61(4):1029–1034. doi:10.1111/trf.16218
  • Hashemian SM, Shafigh N, Afzal G, et al. Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS). Pulmonology. 2021;27(6):486–492. doi:10.1016/j.pulmoe.2020.10.017
  • Mangalmurti N, Hunter CA. Cytokine storms: understanding COVID-19. Immunity. 2020;53(1):19–25. doi:10.1016/j.immuni.2020.06.017
  • Balagholi S, Dabbaghi R, Eshghi P, Mousavi SA, Heshmati F, Mohammadi S. Potential of therapeutic plasmapheresis in treatment of COVID-19 patients: immunopathogenesis and coagulopathy. Transfus Apher Sci. 2020;59(6):102993. doi:10.1016/j.transci.2020.102993
  • Turgutkaya A, Yavaşoğlu İ, Bolaman Z. Application of plasmapheresis for Covid-19 patients. Ther Apher Dial. 2021;25(2):248–249. doi:10.1111/1744-9987.13536
  • Dogan L, Kaya D, Sarikaya T, et al. Plasmapheresis treatment in COVID-19-related autoimmune meningoencephalitis: case series. Brain Behav Immun. 2020;87:155–158. doi:10.1016/j.bbi.2020.05.022
  • Sedokani A, Feizollahzadeh S. Plasmapheresis, anti-ACE2 and anti-FcγRII monoclonal antibodies: a possible treatment for severe cases of COVID-19. Drug Des Devel Ther. 2020;14:2607–2611. doi:10.2147/DDDT.S262491
  • Pourahmad R, Moazzami B, Rezaei N. Efficacy of plasmapheresis and immunoglobulin replacement therapy (IVIG) on patients with COVID-19 [published online ahead of print, 2020 Jul 31]. SN Compr Clin Med. 2020;1–5. doi:10.1007/s42399-020-00438-2
  • Frank RC, Mendez SR, Stevenson EK, Guseh JS, Chung M, Silverman MG. Obesity and the risk of intubation or death in patients with coronavirus disease 2019. Crit Care Med. 2020;48(11):e1097–e1101. doi:10.1097/CCM.0000000000004553
  • Nadler SB, Hidalgo JH, Bloch T. Prediction of blood volume in normal human adults. Surgery. 1962;51(2):224–232.
  • Shkodivskyi P, Dressel A, Handreka R, et al. A case of acute optic neuritis during pregnancy treated by membrane-based therapeutic plasma exchanges without systemic anticoagulation. Transfus Apher Sci. 2021;60(5):103178. doi:10.1016/j.transci.2021.103178
  • Alsaffar H, Martino N, Garrett JP, Adam AP. Interleukin-6 promotes a sustained loss of endothelial barrier function via Janus kinase-mediated STAT3 phosphorylation and de novo protein synthesis. Am J Physiol Cell Physiol. 2018;314(5):C589–C602. doi:10.1152/ajpcell.00235.2017
  • Ji W, Hu Q, Zhang M, et al. The disruption of the endothelial barrier contributes to acute lung injury induced by coxsackievirus A2 infection in mice. Int J Mol Sci. 2021;22(18):9895. doi:10.3390/ijms22189895
  • Tabibi S, Tabibi T, Conic RRZ, Banisaeed N, Streiff MB. Therapeutic plasma exchange: a potential management strategy for critically ill COVID-19 patients. J Intensive Care Med. 2020;35(9):827–835. doi:10.1177/0885066620940259

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.